Market Overview:
The global AFP testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of AFP-positive tumors, rising demand for early diagnosis and treatment, and technological advancements in AFP testing methods. The global AFP testing market is segmented by type into liver cancer, testes cancer, ovarian cancer, biliary tract cancer, stomach cancer, pancreatic cancer and others.
Product Definition:
AFP (alpha-fetoprotein) is a protein produced by the fetal liver and yolk sac. AFP levels rise during the second trimester of pregnancy and peak in the third trimester. AFP is present in both maternal and fetal blood.
AFP testing is used to screen for birth defects, including spina bifida and anencephaly. It may also be used to monitor a pregnancy for problems such as Down syndrome or neural tube defects.
Liver Cancer:
Liver cancer is one of the leading causes of cancer-related deaths in the U.S. According to data published by Cancer Organization, it was stated that liver cancer accounted for approximately 2% of all new cancers diagnosed in 2018 and 5% among adults (50 years) and 4% among children (0 - 19 years). The same source also states that around 11, 380 people were estimated to be diagnosed with liver cancer in 2019 across the globe.
Testes Cancer:
Testes cancer is a disease in which the testicles become enlarged and develop a malignant tumor. It accounts for around 2% of all cancers. The exact cause of testes cancer is unknown, but factors such as genetic mutation, viral infection or chemical exposure are known to trigger the disease.
Uterine Cancer Treatment Market Size, Share & Trends Analysis Report By Type (Metastatic Castration-resistant), By Region (North America: U.S.
Application Insights:
The hospitals and clinics segment dominated the market in 2017. This is attributed to the presence of a strong institutional framework supporting cancer diagnosis, treatment, and research in most countries across the world. Furthermore, this segment will continue to dominate the market over the forecast period due to factors such as availability of advanced healthcare facilities and infrastructure at an institutional level coupled with high spending on medical care by governments in these regions.
The others application segment includes laboratories offering AFP testing services outside hospitals or clinics (such as private laboratories). The growth of this application is driven by increasing demand for rapid testing solutions that help patients avoid long waits for results while undergoing chemotherapy or other treatments at home.
Regional Analysis:
North America dominated the market in 2017 owing to high awareness levels and presence of sophisticated healthcare infrastructure. Moreover, increasing prevalence of cancer is also expected to drive the demand for AFP testing over the forecast period. For instance, as per statistics published by American Cancer Society in 2018, around 1,762 new cases of liver cancer were reported in U.S., which indicates a significant rise compared to previous year.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period due to rising disposable income and improving healthcare facilities especially in developing countries such as India and China. In addition, these factors are expected lead towards an increase in demand for advanced diagnostic procedures including AFP tests during the forecast period in this region as well as others regions globally over next eight years or so till 2030 AD (Due To Accelerated Clock).
Growth Factors:
- Increasing demand for early cancer detection and treatment: The increasing incidence of cancer is one of the major growth drivers for the AFP Testing market. According to a study by the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, accounting for around 8.8 million deaths in 2012. Out of these, lung cancer accounted for 1.6 million deaths, followed by liver cancer (746 000 deaths) and stomach cancer (723 000 deaths). The rising prevalence of various types of cancers is expected to drive the demand for AFP Testing products and services in the coming years.
- Growing awareness about early diagnosis and treatment: There has been a growing awareness among people about the importance of early diagnosis and treatment for various diseases, including cancers. This has led to an increase in demand for diagnostic tests such as AFP Testing products and services worldwide. In addition, governments are also investing heavily in healthcare infrastructure development projects with a view to improve access to quality healthcare facilities across their respective countries. This is likely to create lucrative growth opportunitiesfor players operating intheAFPTestingmarketin thenear future .
Scope Of The Report
Report Attributes
Report Details
Report Title
AFP Testing Market Research Report
By Type
Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others
By Application
Hospitals and Clinics, Others
By Companies
Abbott Laboratories, Becton Dickinson, Biomedical Diagnostics, Bio-Rad Laboratories, Beckman Coulter, Roche Diagnostics, Kreatech Diagnostics, Mackay Life Sciences, Siemens Healthcare, Panacea Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global AFP Testing Market Report Segments:
The global AFP Testing market is segmented on the basis of:
Types
Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Becton Dickinson
- Biomedical Diagnostics
- Bio-Rad Laboratories
- Beckman Coulter
- Roche Diagnostics
- Kreatech Diagnostics
- Mackay Life Sciences
- Siemens Healthcare
- Panacea Pharmaceuticals
Highlights of The AFP Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liver Cancer
- Testes Cancer
- Ovarian Cancer
- Biliary Tract Cancer
- Stomach Cancer
- Pancreatic Cancer
- Others
- By Application:
- Hospitals and Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the AFP Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
AFP Testing is a process that helps to identify and fix problems with your computer's operating system.
Some of the major players in the afp testing market are Abbott Laboratories, Becton Dickinson, Biomedical Diagnostics, Bio-Rad Laboratories, Beckman Coulter, Roche Diagnostics, Kreatech Diagnostics, Mackay Life Sciences, Siemens Healthcare, Panacea Pharmaceuticals.
The afp testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 AFP Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 AFP Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 AFP Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the AFP Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global AFP Testing Market Size & Forecast, 2018-2028
4.5.1 AFP Testing Market Size and Y-o-Y Growth
4.5.2 AFP Testing Market Absolute $ Opportunity
Chapter 5 Global AFP Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 AFP Testing Market Size Forecast by Type
5.2.1 Liver Cancer
5.2.2 Testes Cancer
5.2.3 Ovarian Cancer
5.2.4 Biliary Tract Cancer
5.2.5 Stomach Cancer
5.2.6 Pancreatic Cancer
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global AFP Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 AFP Testing Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global AFP Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 AFP Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America AFP Testing Analysis and Forecast
9.1 Introduction
9.2 North America AFP Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America AFP Testing Market Size Forecast by Type
9.6.1 Liver Cancer
9.6.2 Testes Cancer
9.6.3 Ovarian Cancer
9.6.4 Biliary Tract Cancer
9.6.5 Stomach Cancer
9.6.6 Pancreatic Cancer
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America AFP Testing Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe AFP Testing Analysis and Forecast
10.1 Introduction
10.2 Europe AFP Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe AFP Testing Market Size Forecast by Type
10.6.1 Liver Cancer
10.6.2 Testes Cancer
10.6.3 Ovarian Cancer
10.6.4 Biliary Tract Cancer
10.6.5 Stomach Cancer
10.6.6 Pancreatic Cancer
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe AFP Testing Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific AFP Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific AFP Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific AFP Testing Market Size Forecast by Type
11.6.1 Liver Cancer
11.6.2 Testes Cancer
11.6.3 Ovarian Cancer
11.6.4 Biliary Tract Cancer
11.6.5 Stomach Cancer
11.6.6 Pancreatic Cancer
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific AFP Testing Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America AFP Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America AFP Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America AFP Testing Market Size Forecast by Type
12.6.1 Liver Cancer
12.6.2 Testes Cancer
12.6.3 Ovarian Cancer
12.6.4 Biliary Tract Cancer
12.6.5 Stomach Cancer
12.6.6 Pancreatic Cancer
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America AFP Testing Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) AFP Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) AFP Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) AFP Testing Market Size Forecast by Type
13.6.1 Liver Cancer
13.6.2 Testes Cancer
13.6.3 Ovarian Cancer
13.6.4 Biliary Tract Cancer
13.6.5 Stomach Cancer
13.6.6 Pancreatic Cancer
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) AFP Testing Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 AFP Testing Market: Competitive Dashboard
14.2 Global AFP Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Becton Dickinson
14.3.3 Biomedical Diagnostics
14.3.4 Bio-Rad Laboratories
14.3.5 Beckman Coulter
14.3.6 Roche Diagnostics
14.3.7 Kreatech Diagnostics
14.3.8 Mackay Life Sciences
14.3.9 Siemens Healthcare
14.3.10 Panacea Pharmaceuticals
